Adding to the positive sentiment, the U.S. Postal Service reversed its earlier decision to halt inbound shipments from ...

The SFC’s “ASPIRe” roadmap outlines 12 key initiatives to enhance market access, security, and product offerings.

Medical technology company Becton, Dickinson and Company (NYSE:BDX) will be announcing earnings results tomorrow before market open. Here’s what to look for. BD beat analysts’ revenue ...

The event will showcase how brands, creators and entrepreneurs are leveraging Web3 technology to revolutionize culture and ...

Citi analyst Joanne Wuensch maintained a Buy rating on Becton Dickinson (BDX – Research Report) today. The company’s shares closed last Friday at $229.85. Leverage the power of TipRanks' Smart ...

BDX's acquisition of Edwards Lifesciences’ Critical Care product group and rising free cash flow are positive indicators for future growth. The stock's momentum is improving, but geopolitical ...

Barclays analyst Matt Miksic maintained a Buy rating on Becton Dickinson (BDX – Research Report) today and set a price target of $278.00. The company’s shares closed yesterday at $227.21.

In trading on Thursday, shares of Becton, Dickinson & Co (Symbol: BDX) crossed below their 200 day moving average of $233.84, changing hands as low as $232.30 per share. Becton, Dickinson & Co ...

For the quarter ended December 2024, Becton Dickinson (BDX) reported revenue of $5.17 billion, up 9.8% over the same period last year. EPS came in at $3.43, compared to $2.68 in the year-ago quarter.